Evidence map›Paper›PMID 23249685›Full record

ArticleThe American journal of tropical medicine and hygiene2013

Incidence of malaria among mosquito collectors conducting human landing catches in western Kenya.

John E Gimnig, Edward D Walker, Peter Otieno, Jackline Kosgei, George Olang, Maurice Ombok, John Williamson, Doris Marwanga, Daisy Abong'o, Meghna Desai and 5 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04149119 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Attractive Targeted Sugar Bait Phase III Trial in Mali

TypeinterventionalSponsorUniversity Clinical Research Center, MaliRan2022 to 2024Enrolled2,100ConditionsVector TransmissionArmsAttractive Target Sugar Baits (ATSB)
NCT05219565 nacompletednot on this mapstarted 2022, after this paper: background citation

Phase III, Open-label, Community-based, Cluster Randomised Controlled Trial to Evaluate the Efficacy, Cost-effectiveness, and Acceptability of Attractive Targeted Sugar Baits (ATSB) for Malaria Burden Reduction in Western Kenya

TypeinterventionalSponsorLiverpool School of Tropical MedicineRan2022 to 2024Enrolled2,962ConditionsMalariaArmsAttractive Targeted Sugar Bait (ATSB)
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

John E GimnigDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. jgimnig@cdc.gov
Edward D Walker
Peter Otieno
Jackline Kosgei
George Olang
Maurice Ombok
John Williamson
Doris Marwanga
Daisy Abong'o
Meghna Desai
Simon Kariuki
Mary J Hamel
Neil F Lobo
John Vulule
M Nabie Bayoh
Centers for Disease Control and Prevention · USInstitute of Entomology · CZKenya Medical Research Institute · KEUniversity of Notre Dame · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human landing catch (HLC) has long been the gold standard for estimating malaria transmission by mosquitoes, but has come under scrutiny because of ethical concerns of exposing collectors to infectious bites. We estimated the incidence of Plasmodium falciparum malaria infection in a cohort of 152 persons conducting HLCs and compared it with that of 147 non-collectors in western Kenya. Participants were presumptively cleared of malaria with Coartem™ (artemether-lumefantrine) and tested for malaria every 2 weeks for 12 weeks. The HLC collections were conducted four nights per week for six weeks. Collectors were provided chemoprophylaxis with Malarone™ (atovaquone-proguanil) during the six weeks of HLC activities and one week after HLC activities were completed. The incidence of malaria was 96.6% lower in collectors than in non-collectors (hazard ratio = 0.034, P < 0.0001). Therefore, with proper prophylaxis, concern about increased risk of malaria among collectors should not be an impediment to conducting HLC studies.

Indexed as

AdolescentAdultAtovaquoneCohort StudiesDrug CombinationsHumansIncidenceKenyaLogistic ModelsMalaria, FalciparumMaleMiddle AgedProguanilProspective StudiesRisk FactorsSurveys and QuestionnairesAtovaquoneatovaquone, proguanil drug combinationDrug CombinationsProguanil

Identifiers

PMID23249685
PMCPMC3583321
OpenAlexW2129166045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.